These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 13354306)

  • 1. The production in experimental animals of high titre immune sera using influenza vaccines mixed with oil adjuvants.
    FURESZ J
    Acta Microbiol Acad Sci Hung; 1956; 3(4):363-71. PubMed ID: 13354306
    [No Abstract]   [Full Text] [Related]  

  • 2. [IDENTIFICATION OF INFLUENZA A2 STRAINS WITH THE COMPLEMENT FIXATION REACTION USING IMMUNE SERA WITH S-PARTICLES].
    GERTH HJ
    Z Hyg Infektionskr; 1964 Apr; 149():430-9. PubMed ID: 14214971
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of the neutralizing activity of immune sera to various types of influenza virus and Sendai parainfluenza virus.
    YABROV AA
    Probl Virol; 1961; 6():198-202. PubMed ID: 14040350
    [No Abstract]   [Full Text] [Related]  

  • 4. CLINICAL TRIALS OF OIL-ADJUVANT INFLUENZA VACCINES, 1960-3. REPORT TO THE MEDICAL RESEARCH COUNCIL BY ITS COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.
    UJHAZY V
    Br Med J; 1964 Aug; 2(5404):267-71. PubMed ID: 14160206
    [No Abstract]   [Full Text] [Related]  

  • 5. Adaptation of influenza B virus to mice by use of certain adjuvants.
    JONES M
    Proc Soc Exp Biol Med; 1950 Nov; 75(2):309-11. PubMed ID: 14808242
    [No Abstract]   [Full Text] [Related]  

  • 6. SEROLOGICAL STUDIES ON ADULT VOLUNTEERS INOCULATED WITH OIL-ADJUVANT ASIAN INFLUENZA VACCINE. REPORT TO THE M.R.C. COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.
    HOBSON D; LANE CA; BEARE AS; CHIVERS CP
    Br Med J; 1964 Aug; 2(5404):271-4. PubMed ID: 14160207
    [No Abstract]   [Full Text] [Related]  

  • 7. NEUTRALIZATION IN VITRO OF MOUSE LEUKEMIA VIRUS BY SPECIFIC IMMUNE SERUM. IMPORTANCE OF VIRUS TITRATION.
    GROSS L
    Proc Soc Exp Biol Med; 1965 Jun; 119():420-7. PubMed ID: 14330895
    [No Abstract]   [Full Text] [Related]  

  • 8. A COMPARATIVE TRIAL OF OIL-ADJUVANT AND AQUEOUS POLYVALENT INFLUENZA VACCINES.
    HOWELL RW; MACKENZIE AB
    Br J Ind Med; 1964 Oct; 21(4):265-8. PubMed ID: 14249894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A TRIAL OF OIL-ADJUVANT INFLUENZA VACCINE IN A NON-EPIDEMIC SEASON.
    HOWELL RW; STOTT AN
    Br J Ind Med; 1964 Oct; 21(4):259-64. PubMed ID: 14249893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule.
    HENNESSY AV; DAVENPORT FM
    Public Health Rep (1896); 1961 May; 76(5):411-9. PubMed ID: 13713365
    [No Abstract]   [Full Text] [Related]  

  • 11. NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. I. DEVELOPMENT AND ANIMAL IMMUNE RESPONSE.
    WOODHOUR AF; METZGAR DP; STIM TB; TYTELL AA; HILLEMAN MR
    Proc Soc Exp Biol Med; 1964 Jun; 116():516-23. PubMed ID: 14193390
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of the method of administering the antigen on the titre of tetanic, edematic, septic, anti beta and anti epsilon antitoxins of Welchia agni and on the distribution of proteins in blood serum].
    Katitch R; Voukitchevitch Z; Stephanovitch R; Gadjanski G
    Rev Immunol (Paris); 1970; 34(3):127-39. PubMed ID: 4195887
    [No Abstract]   [Full Text] [Related]  

  • 13. [The influenza virus and other viruses. Antiinfluenza vaccine adjuvants. The hemagglutination phenomenon. Non-specific inhibition. II].
    LACORTE JG
    Rev Bras Med; 1960 Apr; 17():334-8. PubMed ID: 13758108
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant influenza adenovirus vaccine.
    MEIKLEJOHN G
    JAMA; 1962 Feb; 179():594-7. PubMed ID: 14472203
    [No Abstract]   [Full Text] [Related]  

  • 15. [Novel adjuvants in vaccine development].
    Kaufmann AM; Schmidt-Ott R; Prechtl A
    MMW Fortschr Med; 2011 Jan; 152 Suppl 4():115-8. PubMed ID: 21598461
    [No Abstract]   [Full Text] [Related]  

  • 16. An evaluation of an adjuvant influenza virus vaccine tested against influenza B in 1954-1955.
    CRYNS WF; DAVENPORT FM; HENNESSY AV; HOUSER HB
    Am J Hyg; 1956 Nov; 64(3):304-13. PubMed ID: 13372524
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of zymosan and poly (I:C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine.
    Shin JH; Noh JY; Kim KH; Park JK; Lee JH; Jeong SD; Jung DY; Song CS; Kim YC
    J Control Release; 2017 Nov; 265():83-92. PubMed ID: 28890214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACUTE RESPIRATORY DISEASE IN INFANCY AND CHILDHOOD: PRESENT UNDERSTANDING AND PROSPECTS FOR PREVENTION.
    CHANOCK RM; PARROTT RH
    Pediatrics; 1965 Jul; 36():21-39. PubMed ID: 14313363
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the relationships between antigen supply and antibody formation. Part I. Description of a method for production of high titer immune sera by means of permanent antigenic stimulation].
    DRESCHER J
    Zentralbl Bakteriol; 1960 Jan; 177():149-60. PubMed ID: 13855731
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic classification of poliomyelitis viruses. IV. Results of typing by neutralization of prototype viruses with antiserum produced by vaccinating monkeys with unknown strain and an adjuvant.
    SALK JE; YOUNGNER JS; LEWIS LJ; BENNETT BL
    Am J Hyg; 1951 Sep; 54(2):255-67. PubMed ID: 14877806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.